NHS Information Authority

Data Standards Programme

DERMATOLOGIST BODY SITE

Each DERMATOLOGIST BODY SITE

	may be the skin cancer site for one and only one SKIN CANCER CARE SPELL
	may be a site for one or more SKIN CANCER LESION

SKIN CANCER CARE SPELL

Each SKIN CANCER CARE SPELL

	may be malignant melanoma, Karposi's sarcoma, B-cell lymphoma or T-cell lymphoma occurring at one or more DERMATOLOGIST BODY SITE
	may be care for one or more SKIN CANCER LESION
	may be care for one B-cell or T-cell lymphoma where there are one or more SKIN LYMPHOMA MORPHOLOGY

SKIN CANCER LESION

NEW LESIONS TREATED NUMBER

The number of new SKIN CANCER LESIONS treated during the attendance. The number of new [DELETED] treated during the attendance.

References:
National Cancer Data Set Version 2.1_ISB October 2002

RECURRENT LESIONS TREATED NUMBER

The number of SKIN CANCER LESIONS treated during the attendance that are a recurrence of a previous lesion. The number of [DELETED] treated during the attendance that are a recurrence of a previous lesion.

References:
National Cancer Data Set Version 2.1_ISB October 2002

SKIN CANCER LESION IDENTIFIER

SKIN CANCER SUBSEQUENT DIAGNOSIS DATE

The date on which an additional or recurrence of an existing SKIN CANCER LESION was diagnosed subsequent to an original diagnosis. The date on which an additional or recurrence of an existing [DELETED] was diagnosed subsequent to an original diagnosis.

References:
National Cancer Data Set Version 2.1_ISB October 2002

DERMATOLOGIST BODY SITE (SKIN CANCER LESION)

Format/length:	an1
HES item:
National Codes:
Default Codes:

Notes:
If the diagnosis is Basal Cell Carcinoma or Squamous Cell Carcinoma, this is the DERMATOLOGIST BODY SITE of each SKIN CANCER LESION as there may be several lesions for a single SKIN CANCER CARE SPELL. If the diagnosis is Basal Cell Carcinoma or Squamous Cell Carcinoma, this is the DERMATOLOGIST BODY SITE of each [DELETED] as there may be several lesions for a single SKIN CANCER CARE SPELL.

This data element is also known by these names:

Context	Alias
plural	DERMATOLOGIST BODY SITES (SKIN CANCER LESION)

SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER LESION)

Format/length:	n3
HES item:
National Codes:	Press Definition button for the National Codes
Default Codes:

Notes:
If the diagnosis is Basal Cell Carcinoma or Squamous Cell Carcinoma, this is the SKIN CANCER LARGEST CLINICAL DIAMETER of each SKIN CANCER LESION as there may be several lesions for a single SKIN CANCER CARE SPELL. If the diagnosis is Basal Cell Carcinoma or Squamous Cell Carcinoma, this is the SKIN CANCER LARGEST CLINICAL DIAMETER of each [DELETED] as there may be several lesions for a single SKIN CANCER CARE SPELL.

This data element is also known by these names:

Context	Alias
plural	SKIN CANCER LARGEST CLINICAL DIAMETER (SKIN CANCER LESIONS)

HP420

Model View Diagram - Overview

HP420 - Cancer Care - Skin and Sarcoma site specific data

1. This diagram shows the class types relevant to site specfic data in the treatment of cancer for skin and sarcoma.

2. A CANCER CARE SPELL may be a SKIN CANCER CARE SPELL or SARCOMA CARE SPELL depending on the type of cancer being treated.

3. SARCOMA CARE SPELL is related to a particular BODY SITE.

4. The SKIN CANCER CARE SPELL is related to a DERMATOLOGIST BODY SITE and may have a number of SKIN CANCER LESIONS diagnosed which are found at other DERMATOLOGIST BODY SITES. Each SKIN CANCER CARE SPELL may have a number of different SKIN LYMPHOMA MORPHOLOGIES.

4. The SKIN CANCER CARE SPELL is related to a DERMATOLOGIST BODY SITE and may have a number of [DELETED] diagnosed which are found at other DERMATOLOGIST BODY SITES. Each SKIN CANCER CARE SPELL may have a number of different SKIN LYMPHOMA MORPHOLOGIES.

5. Each CANCER CARE SPELL may have a primary PATIENT DIAGNOSIS and a number of PERSON OBSERVATIONS WITHIN CARE SPELLS, one of which will be the SARCOMA CONDITION.